Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
Is Invesco Dynamic Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
11:20am, Friday, 09'th Dec 2022 Zacks Investment Research
Smart Beta ETF report for PJP
Zacks Market Edge Highlights: LLY, PFE, JPM, ULTA, QQQ
10:41am, Friday, 09'th Dec 2022 Zacks Investment Research
LLY, PFE, JPM, ULTA, QQQ have been highlighted in this Market Edge article.
Will There be a Recession in 2023?
07:16pm, Thursday, 08'th Dec 2022 Zacks Investment Research
Tracey Ryniec and John Blank are back with their annual look at the economy and how to invest in the new year.
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
03:15pm, Thursday, 08'th Dec 2022 The Motley Fool
The three companies are changing the pharmaceutical industry.
2 Top Index Funds Growth Stock Investors Can Buy With Confidence Before 2023
01:33pm, Thursday, 08'th Dec 2022 The Motley Fool
Growth stocks have been hammered this year, but these index funds have a track record of outperformance.
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
10:15am, Thursday, 08'th Dec 2022
The three companies are changing the pharmaceutical industry.
Relative Strength Found Within These 3 Medical Stocks
10:35pm, Monday, 05'th Dec 2022 Zacks Investment Research
The Zacks Medical sector has modestly outperformed the S&P 500 over the last three months, up more than 7% vs. the general market's 4% gain.
12 Analysts Have This to Say About Eli Lilly
09:02pm, Monday, 05'th Dec 2022 Benzinga
Within the last quarter, Eli Lilly (NYSE:LLY) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
2
8
2
0
0
Last 30D
0
1
What 12 Analyst Ratings Have To Say About Eli Lilly
07:04pm, Monday, 05'th Dec 2022 Benzinga
Over the past 3 months, 12 analysts have published their opinion on Eli Lilly (NYSE:LLY) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company
Relative Strength Found Within These 3 Medical Stocks
06:48pm, Monday, 05'th Dec 2022
The Zacks Medical sector has modestly outperformed the S&P 500 over the last three months, up more than 7% vs. the general market's 4% gain.
Anavex's (AVXL) Lead Alzheimer's Drug Meets Study Goal
06:03pm, Monday, 05'th Dec 2022 Zacks Investment Research
Top-line data from a phase IIb/III study shows that Anave's (AVXL) lead drug exhibited statistical and clinical improvement in cognition and function in patients with early Alzheimer's disease.
Expert Ratings for Eli Lilly
05:06pm, Monday, 05'th Dec 2022 Benzinga
Within the last quarter, Eli Lilly (NYSE:LLY) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
2
8
2
0
0
Last 30D
0
1
Expect heavy market selling early next year, says Worth Charting's Carter Worth
03:01pm, Monday, 05'th Dec 2022
Carter Worth, Worth Charting CEO, joins 'The Exchange' to give the technical take on Eli Lilly and XBI.
Even After This Year's Melt-Up, Runway Remains for LLY Stock
06:15am, Monday, 05'th Dec 2022
Pharmaceutical stocks overall have fared well during this tough year for the market, but Eli Lilly (NYSE: LLY ) has been a pharma name that's truly “crushed it” so far in 2022. LLY stock has ralli
Dividend Champion, Contender, And Challenger Highlights: Week Of December 4
05:29am, Sunday, 04'th Dec 2022 Seeking Alpha
Weekly summary of dividend activity for Dividend Champions, Contenders, Challengers. Read more to see companies with upcoming ex-dividend dates.
